장기 보존 시장 : 보존 솔루션, 장기 유형, 기술, 최종사용자별 - 세계 예측(2025-2030년)

The Organ Preservation Market was valued at USD 503.93 million in 2023, expected to reach USD 541.48 million in 2024, and is projected to grow at a CAGR of 7.72%, to USD 848.57 million by 2030.

Organ preservation refers to the set of medical practices designed to preserve organs between excision and transplantation, ensuring they remain viable for successful transplantation. The necessity of organ preservation stems from the critical demand-supply disparity in organ transplants, where timely and effective preservation techniques can enhance organ viability, potentially saving countless lives. These techniques are applied across liver, kidney, heart, lung, and pancreas preservation, serving primarily hospitals, transplant centers, and research institutions. The end-use scope includes specialized labs developing preservation solutions and medical centers focusing on routine transplants.

Key growth influencers in the organ preservation market include advancements in preservation technologies like hypothermic machine perfusion, improving organ viability during transportation. The increasing number of organ transplants globally coupled with supportive regulatory frameworks further propels market growth. Additionally, burgeoning research initiatives focusing on extending preservation times and improving outcomes contribute significantly. Emerging potential opportunities exist in the development of cryopreservation and supercooling techniques, promising to redefine preservation time frames and quality, thus attracting investment and innovation attention. For businesses to leverage these, collaboration with research institutions and investment in R&D are recommended, especially in refining organ transportation logistics and developing portable perfusion devices.

Despite the promising growth, challenges remain, like logistic issues in organ transport and the high costs associated with advanced preservation technologies, limiting market expansion in developing regions. Moreover, the complexity of regulatory compliance poses a hurdle for new entrants. Innovative areas lie in improving less invasive perfusion methods and enhancing real-time monitoring of organ conditions during preservation. The market is highly dynamic, characterized by rapid technological advancements and a push towards personalized medicine. Businesses should focus on collaborative partnerships and technology integration to maintain competitive advantages and meet evolving healthcare needs effectively, ensuring alignment with sustainability goals and regulatory standards to address market challenges.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Organ Preservation Market

The Organ Preservation Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising number of organ transplantation surgeries and instances of the multi-organ failure
  • Growing demand for preserving solutions for immediate availability of the organ
  • Constant increase in the awareness of organ donation
• Market Restraints
  • Limited awareness and affordaboility constraints of organ preservation techniques
• Market Opportunities
  • Rapid growth in the R&D for improved organ preservation methods and solutions
  • Ongoing extension of clinical service offerings and inventory expansion
• Market Challenges
  • Availability of the artificial organs

Porter's Five Forces: A Strategic Tool for Navigating the Organ Preservation Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Organ Preservation Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Organ Preservation Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Organ Preservation Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Organ Preservation Market

A detailed market share analysis in the Organ Preservation Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Organ Preservation Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Organ Preservation Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Organ Preservation Market

A strategic analysis of the Organ Preservation Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Organ Preservation Market, highlighting leading vendors and their innovative profiles. These include 21st Century Medicine, Artivion, Inc., AVIONORD S.R.L., BioLife Solutions Inc., Bridge to Life Ltd., CARDIOLINK S.L., Carnamedica, Dr. Franz Kohler Chemie GmbH, EBERS MEDICAL TECHNOLOGY SL, Essential Pharmaceuticals, LLC by Accord Healthcare Limited, Global Transplant Solutions, Inc., Hemarina SA, Institut Georges Lopez, Lifeline Scientific, Inc., Organ Preservation Solutions Ltd., OrganOx Limited, Paragonix Technologies, Inc., Preservation Solutions, Inc., S.A.L.F. S.p.A., Sandor Medicaids Pvt. Ltd., SAS Advanced Life Solutions, ScubaTx Limited, TransMedics, Inc., TX Innovations B.V., Vascular Perfusion Solutions, Inc., and XVIVO AB.

Market Segmentation & Coverage

This research report categorizes the Organ Preservation Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Preservation Solution, market is studied across Celsior Solution, Custodial HTK, IGL-1 Solution, Perfadex, and University of Wisconsin (UW).
• Based on Organ Type, market is studied across Heart, Kidneys, Liver, and Lung.
• Based on Technique, market is studied across Controlled Oxygenated Rewarming, Ex vivo Machine Perfusion, Hypothermic Machine Perfusion, Normothermic Machine Perfusion, and Static Cold Storage.
• Based on End-User, market is studied across Hospitals, Organ Transplant Centers, and Specialty Clinics.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising number of organ transplantation surgeries and instances of the multi-organ failure
    • 5.1.1.2. Growing demand for preserving solutions for immediate availability of the organ
    • 5.1.1.3. Constant increase in the awareness of organ donation
  • 5.1.2. Restraints
    • 5.1.2.1. Limited awareness and affordaboility constraints of organ preservation techniques
  • 5.1.3. Opportunities
    • 5.1.3.1. Rapid growth in the R&D for improved organ preservation methods and solutions
    • 5.1.3.2. Ongoing extension of clinical service offerings and inventory expansion
  • 5.1.4. Challenges
    • 5.1.4.1. Availability of the artificial organs
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Organ Preservation Market, by Preservation Solution

• 6.1. Introduction
• 6.2. Celsior Solution
• 6.3. Custodial HTK
• 6.4. IGL-1 Solution
• 6.5. Perfadex
• 6.6. University of Wisconsin (UW)

7. Organ Preservation Market, by Organ Type

• 7.1. Introduction
• 7.2. Heart
• 7.3. Kidneys
• 7.4. Liver
• 7.5. Lung

8. Organ Preservation Market, by Technique

• 8.1. Introduction
• 8.2. Controlled Oxygenated Rewarming
• 8.3. Ex vivo Machine Perfusion
• 8.4. Hypothermic Machine Perfusion
• 8.5. Normothermic Machine Perfusion
• 8.6. Static Cold Storage

9. Organ Preservation Market, by End-User

• 9.1. Introduction
• 9.2. Hospitals
• 9.3. Organ Transplant Centers
• 9.4. Specialty Clinics

10. Americas Organ Preservation Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Organ Preservation Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Organ Preservation Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
  • 13.3.1. HRSA Announces Organ Procurement and Transplantation Network Modernization Initiative
  • 13.3.2. Paragonix Technologies Raises USD 24M in Series B Led by Signet Healthcare Partners
  • 13.3.3. Paragonix Launches Comprehensive Digital Platform for Real-Time Tracking of Donor Organs Destined for Transplantation
  • 13.3.4. The biotechnology company HEMARINA obtains the CE mark for its HEMO2life technology
  • 13.3.5. NHS Blood and Transplant launches pound 20 million research units
  • 13.3.6. OrganOx announces partnership with Ochre Bio
  • 13.3.7. Breakthrough device designation granted Lifecradle organ preservation system
  • 13.3.8. TransMedics Receives FDA PMA Approval of OCS DCD Heart Indication
  • 13.3.9. FDA approves novel organ preservation device developed across Biomedical Engineering and Surgery
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. 21st Century Medicine
• 2. Artivion, Inc.
• 3. AVIONORD S.R.L.
• 4. BioLife Solutions Inc.
• 5. Bridge to Life Ltd.
• 6. CARDIOLINK S.L.
• 7. Carnamedica
• 8. Dr. Franz Kohler Chemie GmbH
• 9. EBERS MEDICAL TECHNOLOGY SL
• 10. Essential Pharmaceuticals, LLC by Accord Healthcare Limited
• 11. Global Transplant Solutions, Inc.
• 12. Hemarina SA
• 13. Institut Georges Lopez
• 14. Lifeline Scientific, Inc.
• 15. Organ Preservation Solutions Ltd.
• 16. OrganOx Limited
• 17. Paragonix Technologies, Inc.
• 18. Preservation Solutions, Inc.
• 19. S.A.L.F. S.p.A.
• 20. Sandor Medicaids Pvt. Ltd.
• 21. SAS Advanced Life Solutions
• 22. ScubaTx Limited
• 23. TransMedics, Inc.
• 24. TX Innovations B.V.
• 25. Vascular Perfusion Solutions, Inc.
• 26. XVIVO AB